Temporal Trends and Early Outcomes of Transcatheter versus Surgical Mitral Valve Repair in Atrial Fibrillation Patients

Table 4

Factors associated with in-hospital death undergoing TMVR.

Variables	Univariate logistic regression			Multivariate logistic regression
	OR	95% CI	value	OR	95% CI	value
LOS >5 days	8.54	5.55-13.15	<0.001	5.29	3.16–8.87	<0.001
Dyslipidemia	0.46	0.31–0.69	<0.001	0.46	0.3–0.69	<0.001
Cerebrovascular disease	3.16	1.85–5.39	<0.001	2.78	1.46–5.3	0.002
Heart failure with reduced ejection fraction	2.06	1.1–3.89	0.02	2.32	1.22–4.44	0.011
Urgent/emergent admission	4.57	3.09–6.78	<0.001	1.78	1.11–2.86	0.018
Heart failure with preserved ejection fraction	1.82	0.95–3.49	0.07	1.93	0.99–3.75	0.054
Renal disease	1.9	1.3–2.8	<0.001	1.66	0.95–2.87	0.073
Smoke	0.57	0.36–0.91	0.02	0.68	0.42–1.1	0.116
Charlson comorbidity index	1.15	1.05–1.27	<0.001	0.89	0.76–1.04	0.143
Paraplegia	6.18	2.38-16.07	<0.001	1.63	0.51–5.17	0.407
Myocardial infarction	1.7	1.02–2.85	0.040	1.22	0.69–2.15	0.498
Age >75	0.78	0.53–1.14	0.190
AIDS	NA	NA	NA
Alcohol use	NA	NA	0.980
Anemia	1.49	0.68–3.25	0.310
Chronic pulmonary disease	0.9	0.58–1.42	0.660
Dementia	0.46	0.06–3.33	0.440
Diabetes	0.76	0.42–1.37	0.360
Female	0.91	0.62–1.34	0.640
Malignant cancer	1.07	0.39–2.94	0.890
Metastatic solid tumor	0	0-Inf	0.980
Liver disease	1.11	0.35–3.54	0.860
Obesity	0.72	0.38–1.35	0.300
Paroxysmal AF	0.96	0.64–1.43	0.830
Peptic ulcer disease	1.14	0.41–3.13	0.80
Peripheral vascular disease	1.3	0.81–2.07	0.280
Prior CABD	0.84	0.41–1.75	0.650
Prior PCI	0.57	0.26–1.23	0.150
Prior PPM/ICD	0.73	0.4–1.31	0.290
Prior stroke	0.72	0.36–1.43	0.340
Rheumatic disease	1.44	0.84–2.47	0.190

OR: odds ratio; CI: confidence interval; LOS: length of stay; AF: atrial fibrillation; CABG: coronary artery bypass graft surgery; SMVR: surgical mitral valve repair; TMVR: transcatheter mitral valve repair; PPM: permanent pacemaker implant; ICD: implantable cardioverter defibrillator.